Fujita K, Yagi M, Moriwaki S, Yoshida M, et al. A phase 2b, randomized, double-blind, multicenter, vehicle-controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild-to-moderate atopic dermatitis. J Dermatol 2021 Aug 26. doi: 10.1111/1346-8138.16120.
PMID: 34435694